Table 3. Hazard ratios for myocardial infarction, stroke, or death according to baseline CHADS2 and CHA2DS2-VASc scores.
Characteristic | Unadjusted, HR (95% CI) | P Value | Adjusted, HR (95% CI)§ | P Value |
Myocardial infarction or stroke | ||||
CHADS2≥2 vs <2 | 2.03 (1.46–2.81) | <0.001 | 1.87 (1.28–2.72) | 0.001 |
CHADS2 score† | 1.28 (1.13–1.44) | <0.001 | 1.25 (1.08–1.44) | 0.002 |
CHA2DS2-VASc ≥2 vs <2 | 1.72 (1.19–2.48) | 0.004 | 1.63 (1.10–2.47) | 0.02 |
CHA2DS2-VASc score† | 1.18 (1.08–1.29) | <0.001 | 1.18 (1.06–1.31) | 0.002 |
Death | ||||
CHADS2≥2 vs <2 | 4.40 (3.12–6.06) | <0.001 | 3.17 (2.24–4.47) | <0.001 |
CHADS2 score† | 1.74 (1.58–1.92) | <0.001 | 1.60 (1.41–1.80) | <0.001 |
CHA2DS2-VASc ≥2 vs <2 | 11.5 (6.42–20.8) | <0.001 | 8.52 (4.48–16.2) | <0.001 |
CHA2DS2-VASc score† | 1.62 (1.50–1.75) | <0.001 | 1.55 (1.42–1.70) | <0.001 |
Myocardial infarction, stroke or death | ||||
CHADS2≥2 vs <2 | 2.74 (2.19–3.41) | <0.001 | 2.33 (1.81–2.99) | <0.001 |
CHADS2 score† | 1.52 (1.40–1.65) | <0.001 | 1.44 (1.30–1.58) | <0.001 |
CHA2DS2-VASc ≥2 vs <2 | 3.42 (2.58–4.53) | <0.001 | 2.98 (2.17–4.07) | <0.001 |
CHA2DS2-VASc score† | 1.41 (1.33–1.50) | <0.001 | 1.36 (1.26–1.46) | <0.001 |
Adjusted for all clinical variables in Table 1 (except the 5 or 7 variables included in the CHADS2 and CHA2DS2–VASc scoring systems, respectively), LVEF, Killip class, chronic kidney disease and medication at discharge.
Per unit increase in the original 6- or 8-criteria CHADS2 and CHA2DS2-VASc scoring systems, respectively.